Roll-over Study in Patients With Endogenous Cushing's Syndrome for LCI699 (Q63571610)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Roll-over Study in Patients With Endogenous Cushing's Syndrome for LCI699 |
clinical trial |
Statements
Open-label Multi-center Roll-over Study to Assess Long Term Safety in Endogenous Cushing's Syndrome Patients Who Have Completed a Prior Novartis-sponsored Osilodrostat Study and the Investigator Judges to Benefit From Continued Treatment (English)
0 references
5 October 2018
0 references
28 February 2023
0 references
180
0 references
18 year
0 references
75 year
0 references